|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 7/01 | |
| C07K 14/00 | |||
| C07H 21/00 | |||
| A61K 39/12 | |||
| C07K 14/08 |
| (11) | Patento numeris | 2324113 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09805653.4 |
| Europos patento paraiškos padavimo data | 2009-08-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-05-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-02-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/053249 |
| Data | 2009-08-10 |
| (87) | Numeris | WO 2010/017542 |
| Data | 2010-02-11 |
| (30) | Numeris | Data | Šalis |
| 87504 P | 2008-08-08 | US | |
| 218603 P | 2009-06-19 | US |
| (72) |
RICHARDSON, Charles, US
BARGATZE, Robert, US
HAYNES, Joel, US
STEADMAN, Bryan, US
|
| (73) |
Takeda Vaccines, Inc.,
75 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | VIRUS-LIKE PARTICLES COMPRISING COMPOSITE CAPSID AMINO ACID SEQUENCES FOR ENHANCED CROSS REACTIVITY |
| VIRUS-LIKE PARTICLES COMPRISING COMPOSITE CAPSID AMINO ACID SEQUENCES FOR ENHANCED CROSS REACTIVITY |